Aurinia Pharmaceuticals Inc.   Report issue

For profit Phase 3
Founded: Victoria Canada (2012)

Organization Overview

First Clinical Trial
2012
NCT00244842
First Marketed Drug
2021
voclosporin (Lupkynis)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

AURINIA | Aurinia Pharmaceuticals Inc.